Naphthalene

Naphthalene

SCHEMBL16005359

CC(C)(C)OC(=O)O.c1ccc2ccccc2c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
GAA P10253 1/20 0.44
RAB9A P51151 1/20 0.44
CYP2C19 P33261 1/20 0.42
HIF1A Q16665 1/20 0.42
KDM4E B2RXH2 1/20 0.42
BCHE P06276 1/20 0.41
KDM4A O75164 1/20 0.41
GABRB1 P18505 1/20 0.40
GABRB2 P47870 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL1003607 0.85 DGAT1 (0.40) ALDH1A1HSD17B10TSHRTDP1KMT2A
Phenol SCHEMBL7725643 0.84 TDP1 (0.48) ALDH1A1HSD17B10TSHRTDP1KMT2A
Bromobenzene SCHEMBL28196664 0.83 ALDH1A1 (0.46) ALDH1A1HSD17B10TSHRTDP1KMT2A
SCHEMBL28158986 0.81 MEN1 (0.41) ALDH1A1HSD17B10TSHRTDP1KMT2A
(Z)-1,2-Diphenylethene SCHEMBL7565813 0.81 CYP2C19 (0.55) ALDH1A1HSD17B10TSHRTDP1KMT2A
Acetophenone SCHEMBL28515261 0.81 SMN1; SMN2 (0.50) ALDH1A1HSD17B10TSHRTDP1KMT2A
Quinoline SCHEMBL4623672 0.80 ALDH1A1 (0.55) ALDH1A1KMT2AMEN1NPC1GAA
Indole SCHEMBL28167600 0.80 TRPA1 (0.55) ALDH1A1HSD17B10TSHRTDP1KMT2A
SCHEMBL74329 0.80
SCHEMBL21436131 0.80 DGAT1 (0.43) ALDH1A1TSHRTDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2774923-B1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE UNIV NAGOYA NAT UNIV CORP (JP) 2016-05-18 EP disclosed
US-8993777-B2 Method for producing phenyl-substituted heterocyclic derivative NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2015-03-31 US disclosed
US-20140275549-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-09-18 US disclosed
EP-2774923-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE National University Corporation Nagoya University (JP) 2014-09-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275549-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE PAH, DDT, NISCH ALDH1A1 1162/4885HSD17B10 836/4885TSHR 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.